Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in LLY — ELI LILLY & Co

CIK 1000275 TORONTO, A6
Back to LLY Full portfolio

Position in LLY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,920,548,130
-$775,516,957 QoQ
Shares Held
4,262,531
-2.5% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96.52926864344212.ToString("F0")% Shared 2.245449945114769.ToString("F0")% None 1.2252814114431074.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$735,816
PutShares
800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $17,384,840,434 across 18 Drug Manufacturers - General names. LLY ranks #1 (22.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		4,262,531 $3,920,548,130
2 JNJ
Johnson & Johnson
 13,387,402 $3,272,416,535
3 AZN
Astrazeneca PLC
 10,386,455 $2,048,416,647
4 ABBV
AbbVie Inc.
 7,534,148 $1,638,601,840
5 MRK
Merck & Co., Inc.
 13,201,722 $1,588,035,133
6 AMGN
Amgen Inc
 4,471,445 $1,573,277,917
7 PFE
Pfizer Inc
 34,155,840 $959,095,979
8 GILD
Gilead Sciences, Inc.
 5,647,122 $787,039,387

All Filings in LLY

Export CSV
40 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $735,816 800
2026-03-31 $3,920,548,130 4,262,531
2025-12-31 $161,631,887 150,400
2025-12-31 $145,081,813 135,000
2025-12-31 $4,696,065,087 4,369,733
2025-09-30 $3,094,212,212 4,055,324
2025-09-30 $152,600 200
2025-09-30 $76,300,000 100,000
2025-06-30 $155,906 200
2025-06-30 $2,988,093,609 3,833,199
2025-06-30 $77,953,000 100,000
2025-03-31 $3,141,469,262 3,803,646
2025-03-31 $49,554,600 60,000
2024-12-31 $11,580,000 15,000
2024-12-31 $2,100,903,816 2,721,378
2024-09-30 $2,263,049,559 2,554,405
2024-09-30 $44,297,000 50,000
2024-06-30 $2,182,110,653 2,410,160
2024-03-31 $1,814,643,818 2,332,567
2023-12-31 $1,370,717,718 2,351,468
2023-09-30 $1,191,914,561 2,219,043
2023-06-30 $1,108,365,282 2,363,353
2023-03-31 $785,986,722 2,288,704
2022-12-31 $906,901,256 2,478,956
2022-09-30 $12,254,965 37,900
2022-09-30 $762,298,913 2,357,504
2022-06-30 $748,835,443 2,309,581
2022-06-30 $8,462,403 26,100
2022-03-31 $654,287,574 2,284,763
2022-03-31 $11,311,615 39,500
2021-12-31 $671,562,631 2,431,260
2021-09-30 $3,558,170 15,400
2021-09-30 $557,790,275 2,414,154
2021-06-30 $563,359,589 2,454,512
2021-03-31 $470,189,878 2,516,807
2020-12-31 $465,539,320 2,757,281
2020-09-30 $412,311,183 2,785,510
2020-06-30 $400,319,429 2,438,296
2020-03-31 $280,517,081 2,022,182
2020-03-31 $39,535,200 285,000

Report a Problem

Category
Description
Email (optional, for follow-up)